124 related articles for article (PubMed ID: 14759804)
1. Development of efficient viral vectors selective for vascular smooth muscle cells.
Work LM; Nicklin SA; Brain NJ; Dishart KL; Von Seggern DJ; Hallek M; Büning H; Baker AH
Mol Ther; 2004 Feb; 9(2):198-208. PubMed ID: 14759804
[TBL] [Abstract][Full Text] [Related]
2. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation.
Denby L; Nicklin SA; Baker AH
Gene Ther; 2005 Oct; 12(20):1534-8. PubMed ID: 15944729
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
Eslami MH; Gangadharan SP; Sui X; Rhynhart KK; Snyder RO; Conte MS
J Vasc Surg; 2000 Jun; 31(6):1149-59. PubMed ID: 10842152
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors.
Gruchała M; Bhardwaj S; Pajusola K; Roy H; Rissanen TT; Kokina I; Kholová I; Markkanen JE; Rutanen J; Heikura T; Alitalo K; Büeler H; Ylä-Herttuala S
J Gene Med; 2004 May; 6(5):545-54. PubMed ID: 15133765
[TBL] [Abstract][Full Text] [Related]
6. Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob.
Koizumi N; Mizuguchi H; Utoguchi N; Watanabe Y; Hayakawa T
J Gene Med; 2003 Apr; 5(4):267-76. PubMed ID: 12692861
[TBL] [Abstract][Full Text] [Related]
7. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
8. Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus- and adeno-associated virus-directed gene transfer.
Luebke AE; Foster PK; Muller CD; Peel AL
Hum Gene Ther; 2001 May; 12(7):773-81. PubMed ID: 11339894
[TBL] [Abstract][Full Text] [Related]
9. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
10. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy.
Dishart KL; Denby L; George SJ; Nicklin SA; Yendluri S; Tuerk MJ; Kelley MP; Donahue BA; Newby AC; Harding T; Baker AH
J Mol Cell Cardiol; 2003 Jul; 35(7):739-48. PubMed ID: 12818564
[TBL] [Abstract][Full Text] [Related]
11. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
12. Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins.
Qiu C; De Young MB; Finn A; Dichek DA
Hum Gene Ther; 1998 Mar; 9(4):507-20. PubMed ID: 9525312
[TBL] [Abstract][Full Text] [Related]
13. A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells.
Su EJ; Stevenson SC; Rollence M; Marshall-Neff J; Liau G
J Vasc Res; 2001; 38(5):471-8. PubMed ID: 11561149
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of novel AAV2 random libraries displaying peptides of diverse lengths and at diverse capsid positions.
Naumer M; Ying Y; Michelfelder S; Reuter A; Trepel M; Müller OJ; Kleinschmidt JA
Hum Gene Ther; 2012 May; 23(5):492-507. PubMed ID: 22171602
[TBL] [Abstract][Full Text] [Related]
15. Improving clinical efficacy of adeno associated vectors by rational capsid bioengineering.
Sen D
J Biomed Sci; 2014 Nov; 21(1):103. PubMed ID: 25425174
[TBL] [Abstract][Full Text] [Related]
16. A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette.
Wang H; Lieber A
J Virol; 2006 Dec; 80(23):11699-709. PubMed ID: 16987973
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy.
March KL; Madison JE; Trapnell BC
Hum Gene Ther; 1995 Jan; 6(1):41-53. PubMed ID: 7703286
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors.
White SJ; Nicklin SA; Büning H; Brosnan MJ; Leike K; Papadakis ED; Hallek M; Baker AH
Circulation; 2004 Feb; 109(4):513-9. PubMed ID: 14732747
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation.
Douar AM; Poulard K; Stockholm D; Danos O
J Virol; 2001 Feb; 75(4):1824-33. PubMed ID: 11160681
[TBL] [Abstract][Full Text] [Related]
20. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
